The Wall Street Journal's "Pharmalot" reporter Ed Silverman reports on a bill introduced in the California legislature that is aimed at elucidating the mysteries of prescription drug pricing:
As the prices of prescription medicines strain budgets, one California lawmaker wants to force drug makers to reveal their costs in a bid to provide some transparency to the pricing process.
Specifically, the bill would require drug makers to report profits and various operational costs for any medicine that has a price tag of more than $10,000 a year. And these costs would have to be reported to the California Office of Statewide Health Planning and Development, which would then compile an annual report that would be submitted to the state legislature and posted publicly online.
The full article is here.
